Fundz

Neurelis, Inc. reported raising $5.2 Million in an initial SEC Form D filing, from an offering of $15 Million

PRIVATEAug 24, 2018$5.2M of $15M raised

Amount Raised

$5.2 Million

$5.2 Million sold, per SEC Form D (first sale Aug 24, 2018)

Round Type

Venture

San DiegoBiotechnology

Quick answer

Neurelis, Inc. raised $5.2 Million in a funding round, dated August 24, 2018. Neurelis, Inc. is based in San Diego, California, United States.

How much did Neurelis, Inc. raise?
Neurelis, Inc. raised $5.2 Million in a funding round on August 24, 2018.
What does Neurelis, Inc. do?
Neurelis is a specialty pharmaceutical firm that licenses, develops, and commercializes product candidates for epilepsy and the CNS market.
Where is Neurelis, Inc. based and how big is it?
Neurelis, Inc. is based in San Diego, California, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Neurelis, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Axion BioSystems raised $8M on October 5, 2018.
  • GI DYNAMICS, INC. raised $2.2M (Seed) on October 5, 2018.
  • Kula Bio raised $400K (Seed) on October 5, 2018.
  • Keriton raised $500K (Seed) on October 4, 2018.
  • Spyryx Biosciences, Inc. raised $5.9M on October 4, 2018.
  • Biocartis Group NV raised $138K (Pre-Seed) on October 4, 2018.

Who to call at Neurelis, Inc., and when

A new round usually means Neurelis, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Neurelis, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Neurelis, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Neurelis, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Neurelis, Inc.

Location

San Diego, California, United States

About

Neurelis is a specialty pharmaceutical firm that licenses, develops, and commercializes product candidates for epilepsy and the CNS market.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Neurelis, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Neurelis, Inc.'s next move

See what Strategic adds

Neurelis, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.